Categories

Join The Algemeiner

Send a news tip

Algemeiner.com

Search

Swedish Jewish Doctor Alleges Antisemitic Abuse by Colleague After Losing Healthcare Position

Norwegian Authorities Dismiss Case Against Professor Who Called Hamas Massacre ‘Most Beautiful Thing’ of the Century, Sparking Outrage

Iceland Opens First-Ever Jewish Center, Marking Historic Milestone for Country’s Jewish Community

Shopify President Says Antisemitism Is ‘Normalized’ in Canada as Jews Consider Moving Out of Country

University of Miami Israeli Basketball Player Sets New Records at FIBA Under-20 Women’s EuroBasket

British Government to Designate Iran’s IRGC a National Security Threat in Sweeping Crackdown on Foreign Terror Networks

‘Antisemitic Bullying’: Comic Book Publisher Cancels Work After Author Refuses to Accuse Israel of ‘Genocide’

The US Doesn’t Give Israel a Blank Check — and It Gets Many Benefits From the Investment and Alliance

Israel Can’t Win: Palestinian Authority Libels Israel for Arab Crime and for Fighting It

The Clock Is Ticking for Israel’s Global Standing

December 2, 2013 12:48 pm

alcobra-logo

×

Error: Contact form not found.

by Joshua Levitt

Share

Tweet

Email

Israel’s Alcobra Pharmaceuticals has a new non-stimulant treatment for ADHD.

Share this Story:

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

Algemeiner.com

Follow @Algemeiner

The Algemeiner